AcetylcysteineDouble-Blind MethodTreatment OutcomePlacebosRandomized Controlled Trials as TopicExpectorantsFree Radical ScavengersDrug OverdoseAdministration, OralAcetaminophenClinical Trials as TopicDrug IncompatibilityContrast MediaDrug Therapy, CombinationHepatic EncephalopathyCarbocysteinePlacebo EffectDose-Response Relationship, DrugPoisoningTime FactorsSeverity of Illness IndexIopamidolHepatitis, AlcoholicPulmonary Diffusing CapacityAcute Kidney InjuryDrug-Induced Liver InjuryInfusions, IntravenousCross-Over StudiesOndansetronAntioxidantsAzathioprineKidney DiseasesDrug Administration ScheduleAlanine TransaminaseCreatinineKidneyCoronary AngiographyInjections, IntravenousProspective StudiesKidney Failure, ChronicUnited States Food and Drug AdministrationDrug Administration RoutesRats, Sprague-DawleyAdministration, IntranasalRats, WistarInjections, SubcutaneousAdministration, TopicalDisease Models, AnimalInjections, IntraperitonealAdministration, RectalAdministration, CutaneousAdministration, InhalationInjections, IntramuscularBlood PressureRandom AllocationDrug InteractionsBiological AvailabilityArea Under CurveLiverMice, Inbred C57BLHalf-Life